Last reviewed · How we verify
NCT03736512
China Greenlight Registry Study (Post-market)
trial testing GreenLight XPS™ 532 nm Laser System with MoXy™ laser fiber in Benign Prostatic Hyperplasia (BPH) in 30 participants. Completed in 29 November 2021.
30 March 2021
Quick facts
| Lead sponsor | Boston Scientific Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 27 February 2019 |
| Primary completion | 30 March 2021 |
| Estimated completion | 29 November 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- GreenLight XPS™ 532 nm Laser System with MoXy™ laser fiber
Conditions studied
- Benign Prostatic Hyperplasia (BPH) — all drugs for Benign Prostatic Hyperplasia (BPH) →
Sponsor
Boston Scientific Corporation — full company profile →
Who can join
40 and older, male only, with Benign Prostatic Hyperplasia (BPH). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The duration of the study is expected to take approximately 3 years, which includes a recruitment period of approximately 12-months and 2 years (24-months) to complete procedure and follow-up visits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03736512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Benign Prostatic Hyperplasia (BPH)
Currently open trials in the same condition.
- NCT07016620 — Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia · recruiting
- NCT06817733 — Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging · NA · recruiting
- NCT06062875 — Effects of TNF Blockade on Human BPH/LUTS · Phase 2 · recruiting
- NCT04266418 — The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults · NA · recruiting
- NCT04757116 — Post-Market Study to Assess iTind Safety in Comparison to UroLift · NA · recruiting
Other Boston Scientific Corporation trials
Trials by the same sponsor.
- NCT07458243 — Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT · not yet recruiting
- NCT07458217 — Combined CM and STN Stimulation for Motor Epilepsy · NA · not yet recruiting
- NCT07276815 — OverStitch NXT Endoscopic Suture System · NA · not yet recruiting
- NCT07353710 — A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure · NA · not yet recruiting
- NCT07195708 — Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03736512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Scientific Corporation
- Last refreshed: 15 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03736512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing